Volume 19, Number 8—August 2013
Macrolide Resistance of Mycoplasma pneumoniae, South Korea, 2000–2011
|Antimicrobial drug||Strains with 23S rRNA mutation, n = 69
||Strains without 23S rRNA mutation, n = 54
|Tetracycline||0.016 to 0.5||0.06||0.25||0.016 to 0.5||0.06||0.25|
||0.002 to 0.125
||0.004 to 0.125
|Levofloxacin||0.016 to 0.5||0.25||0.25||0.016 to 0.5||0.25||0.5|
|Ciprofloxacin||0.125 to 1.0||0.5||1.0||0.06 to 1.0||0.5||1.0|
|Moxifloxacin||0.008 to 0.06||0.016||0.06||0.004 to 0.06||0.016||0.06|
*MIC50 and MIC90 are minimum inhibitory concentrations at which 50% and 90% of the isolates, respectively, were inhibited by the drug.
Page created: July 19, 2013
Page updated: July 19, 2013
Page reviewed: July 19, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.